The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
Pascale A. Cohen(Lyon 1 Université), Julie A. Vendrell(Inserm), Hubert Lincet(Université Claude Bernard Lyon 1), Caterina F. Donini(Sapienza University of Rome), Nhan Trung Nguyen(Lyon 1 Université)
Cited by 66
Related Papers
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
|The Lancet Oncology|2014|410
Interconnection between Metabolism and Cell Cycle in Cancer
|Trends in Biochemical Sciences|2019|369
Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors
|Endocrine Reviews|2011|302
Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach
|Endocrine Related Cancer|2006|239
Clinical practice guidelines for BRCA1 and BRCA2 genetic testing
|European Journal of Cancer|2021|174